Dr. Timir Paul is a Professor of Medicine and Founding Program Director for Cardiology Fellowship at University of Tennessee at Nashville/St Thomas Hospital. After receiving an MD, he was awarded a Ph.D. and MPH in Cardiovascular Epidemiology by Tulane University, USA. He served as Founding Co-Director of the Center for Cardiovascular Risk Research at East Tennessee State University. He has authored more than 180 publications. His research interests include vein graft interventions, embolic protection devices, subclinical atherosclerosis, coronary microvascular disease, and renal artery stenosis. He serves as an academic editor for PLOS ONE Journal and is on the editorial board for JSCAI, Cardiovascular Revascularization Medicine, and Catheterization Cardiovascular Intervention. His research and recommendations changed the 2021 ACC/AHA and 2018 ESC guidelines on myocardial revascularization by downgrading the use of embolic protection devices in SVG intervention from Class I to Class IIa. He was selected as a SCAI-ELM program circle member and received Young Leadership recognition by Cardiovascular Research Technologies. He is an invitee for the ACC 2022 and ACC 2023 Leadership Forum. He received the best teaching award given by cardiology fellows for 4 consecutive years. He was inducted by Alpha Omega Alpha Medical Honor Society as a faculty member in 2018. He received the Dean’s Distinguished Research Award in 2019.